Neurovascular Devices Market: By Device Type (Cerebral Angioplasty & Stenting Systems, Cerebral Embolization & Aneurysm Coiling Devices, Support Devices and Clot Retrieval), By Therapeutic Application (Stroke, Cerebral Artery Stenosis, Cerebral Aneurysm and Others), By End User (Hospitals, Clinics and Ambulatory Surgical Centers) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Neurovascular Devices Market size was valued at 2.69 Billion in 2022 and is estimated to reach 4.69 Billion by 2029, at a CAGR of 7.4% from 2023 to 2029. Some of the factors propelling the market growth to the rising geriatric population they have a greater risk to prone various diseases and disorders such as cerebrovascular, neurological, and others. Additionally, accessibility to advanced medical facilities for diagnosis and treatment will positively impact the market growth. Furthermore, upgrading in technology and new advanced innovations in the medical facility will fuel the market growth. However, the high cost of the treatment, lack of skilled professionals, and lack of awareness among the individuals will hinder the market growth. Aneurysms are caused by an increase in the prevalence of hypertension, alcohol intake, and smoking. An estimated 6 million Americans are impacted by brain aneurysms each year, according to the Brain Aneurysm Foundation. Every year, the disease claims the lives of half a million people around the world. In the creation of neurothrombectomy devices for the treatment of AIS and accompanying symptoms, a variety of additional technologies are applied. As a result, market expansion is likely to be fueled by the launch of technologically improved items and a quick product approval procedure.

Neurovascular Devices Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

8.3%

Largest Market

North America

Fastest Growing Market

Asia pacific
Neurovascular Devices Market Dynamics

Due to changing lifestyle and rising in the old aged population increasing in the prevalence of numerous of disease and disorders such as neurovascular, and others. Due to modern advance equipped medical sector which provide better medical facilities for earlier diagnosis and treatment propelling the market growth. Additionally, key players are concentrating on developing cost-effective advance medical devices which technological advance and easy to access. Moreover, favorable medical reimbursements and government initiation on the healthcare sector will positively impact on the market growth.

Neurovascular Devices Market Segmentation

By Device Type
  • Cerebral Angioplasty and Stenting Systems
  • Carotid Artery Stents
  • Embolic Protection Systems
  • Neurothrombectomy Devices
  • Cerebral Embolization and Aneurysm Coiling Devices
  • Embolic Coils
  • Flow Diversion Devices
  • Liquid Embolic Agents
  • Support Devices
  • Micro Catheters
  • Micro Guidewires
  • Clot Retrieval
  • Suction
  • Vascular Snares
By Therapeutic
  • Stroke
  • Cerebral Artery Stenosis
  • Cerebral Aneurysm
  • Others
By End User
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

Frequently Asked Questions

The neurovascular devices market key players are: Abbott Laboratories, Johnson & Johnson Services, Inc., Merit Medical Systems, Inc., L. Gore & Associates, Inc., Penumbra, Inc., Terumo Medical Corporation, MicroPort Scientific Corporation, Medtronic PLC, Stryker Corp, Asahi Intecc Co. Ltd., Boston Scientific Corporation, Kaneka Medix Corp, MicroPort Scientific Corporation, LivaNova PLC, Integer Holdings Corporation

The neurovascular devices market size was valued at USD 2.69 billion in 2022

The neurovascular devices market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, and forecast from 2023-2029
  • The report covers in-detail insights about the competitor's overview, key findings, and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments and startup details that are working in the industry
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
1. Executive Summary
2. Global Neurovascular Devices Market Introduction 
2.1.Global Neurovascular Devices Market  - Taxonomy
2.2.Global Neurovascular Devices Market  - Definitions
2.2.1. Device Type 
2.2.2.Therapeutic
2.2.3.End Users
2.2.4.Region
3. Global Neurovascular Devices Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Neurovascular Devices Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Neurovascular Devices Market  By  Device Type , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Cerebral Angioplasty and Stenting Systems
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Carotid Artery Stents
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Embolic Protection Systems
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Neurothrombectomy Devices
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Cerebral Embolization and Aneurysm Coiling Devices
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Embolic Coils
5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Flow Diversion Devices
5.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
5.8. Liquid Embolic Agents
5.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.8.3. Market Opportunity Analysis 
5.9. Support Devices
5.9.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.9.3. Market Opportunity Analysis 
5.10. Micro Catheters
5.10.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.10.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.10.3. Market Opportunity Analysis 
5.11. Micro Guidewires
5.11.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.11.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.11.3. Market Opportunity Analysis 
5.12. Clot Retrieval
5.12.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.12.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.12.3. Market Opportunity Analysis 
6. Global Neurovascular Devices Market  By Therapeutic, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Stroke
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Cerebral Artery Stenosis
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Cerebral Aneurysm
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Others
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7. Global Neurovascular Devices Market  By End Users, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Clinics
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Ambulatory Surgical Centers
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8. Global Neurovascular Devices Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. North America Neurovascular Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1.  Device Type  Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Cerebral Angioplasty and Stenting Systems
9.1.2.Carotid Artery Stents
9.1.3.Embolic Protection Systems
9.1.4.Neurothrombectomy Devices
9.1.5.Cerebral Embolization and Aneurysm Coiling Devices
9.1.6.Embolic Coils
9.1.7.Flow Diversion Devices
9.1.8.Liquid Embolic Agents
9.1.9.Support Devices
9.1.10.Micro Catheters
9.1.11.Micro Guidewires
9.1.12.Clot Retrieval
9.2. Suction Therapeutic Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Stroke
9.2.2.Cerebral Artery Stenosis
9.2.3.Cerebral Aneurysm
9.2.4.Others
9.3.  End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Clinics
9.3.3.Ambulatory Surgical Centers
9.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10. Europe Neurovascular Devices Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1.  Device Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Cerebral Angioplasty and Stenting Systems
10.1.2.Carotid Artery Stents
10.1.3.Embolic Protection Systems
10.1.4.Neurothrombectomy Devices
10.1.5.Cerebral Embolization and Aneurysm Coiling Devices
10.1.6.Embolic Coils
10.1.7.Flow Diversion Devices
10.1.8.Liquid Embolic Agents
10.1.9.Support Devices
10.1.10.Micro Catheters
10.1.11.Micro Guidewires
10.1.12.Clot Retrieval
10.2.  Therapeutic Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Stroke
10.2.2.Cerebral Artery Stenosis
10.2.3.Cerebral Aneurysm
10.2.4.Others
10.3.  End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Clinics
10.3.3.Ambulatory Surgical Centers
10.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11. Asia Pacific (APAC) Neurovascular Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1.  Device Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Cerebral Angioplasty and Stenting Systems
11.1.2.Carotid Artery Stents
11.1.3.Embolic Protection Systems
11.1.4.Neurothrombectomy Devices
11.1.5.Cerebral Embolization and Aneurysm Coiling Devices
11.1.6.Embolic Coils
11.1.7.Flow Diversion Devices
11.1.8.Liquid Embolic Agents
11.1.9.Support Devices
11.1.10.Micro Catheters
11.1.11.Micro Guidewires
11.1.12.Clot Retrieval
11.2.  Therapeutic Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Stroke
11.2.2.Cerebral Artery Stenosis
11.2.3.Cerebral Aneurysm
11.2.4.Others
11.3.  End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Clinics
11.3.3.Ambulatory Surgical Centers
11.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12. Middle East and Africa (MEA) Neurovascular Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1.  Device Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Cerebral Angioplasty and Stenting Systems
12.1.2.Carotid Artery Stents
12.1.3.Embolic Protection Systems
12.1.4.Neurothrombectomy Devices
12.1.5.Cerebral Embolization and Aneurysm Coiling Devices
12.1.6.Embolic Coils
12.1.7.Flow Diversion Devices
12.1.8.Liquid Embolic Agents
12.1.9.Support Devices
12.1.10.Micro Catheters
12.1.11.Micro Guidewires
12.1.12.Clot Retrieval
12.2.  Therapeutic Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Stroke
12.2.2.Cerebral Artery Stenosis
12.2.3.Cerebral Aneurysm
12.2.4.Others
12.3.  End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Clinics
12.3.3.Ambulatory Surgical Centers
12.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13. Latin America Neurovascular Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1.  Device Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Cerebral Angioplasty and Stenting Systems
13.1.2.Carotid Artery Stents
13.1.3.Embolic Protection Systems
13.1.4.Neurothrombectomy Devices
13.1.5.Cerebral Embolization and Aneurysm Coiling Devices
13.1.6.Embolic Coils
13.1.7.Flow Diversion Devices
13.1.8.Liquid Embolic Agents
13.1.9.Support Devices
13.1.10.Micro Catheters
13.1.11.Micro Guidewires
13.1.12.Clot Retrieval
13.2.  Therapeutic Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Stroke
13.2.2.Cerebral Artery Stenosis
13.2.3.Cerebral Aneurysm
13.2.4.Others
13.3.  End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Clinics
13.3.3.Ambulatory Surgical Centers
13.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Abbott Laboratories
14.2.2.Johnson & Johnson Services, Inc.
14.2.3.Merit Medical Systems, Inc.
14.2.4.W. L. Gore & Associates, Inc.
14.2.5.Penumbra, Inc.
14.2.6.Terumo Medical Corporation
14.2.7.MicroPort Scientific Corporation
14.2.8.Medtronic PLC
14.2.9.Stryker Corp
14.2.10.Asahi Intecc Co. Ltd.
14.2.11.Boston Scientific Corporation
14.2.12.Kaneka Medix Corp
14.2.13.MicroPort Scientific Corporation
14.2.14.LivaNova PLC
14.2.15.Integer Holdings Corporation
15. Research Methodology 
16. Appendix and Abbreviations 
  • Abbott Laboratories
  • Johnson & Johnson Services, Inc.
  • Merit Medical Systems, Inc.
  • W. L. Gore & Associates, Inc.
  • Penumbra, Inc.
  • Terumo Medical Corporation
  • MicroPort Scientific Corporation
  • Medtronic PLC
  • Stryker Corp
  • Asahi Intecc Co. Ltd.
  • Boston Scientific Corporation
  • Kaneka Medix Corp
  • MicroPort Scientific Corporation
  • LivaNova PLC
  • Integer Holdings Corporation

Adjacent Markets